Utilizing an Ingestible Biosensor to Assess Real-Time Medication Adherence

Journal of Medical Toxicology

Volumn 11, Issue 4, 2015, Pages 439-444

  Chai, Peter R ^a   Castillo Mancilla, Jose ^c   Buffkin, Eric ^b   Darling, Chad ^a   Rosen, Rochelle K ^e   Horvath, Keith J ^f   Boudreaux, Edwin D ^a   Robbins, Gregory K ^d   Hibberd, Patricia L ^d   Boyer, Edward W ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b eTect BIO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BROWN UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Antiretroviral therapy; Biosensors; HAART; Medication adherence

Indexed keywords

GELATIN;

ARTICLE; BIOMETRY; BIOSENSOR; CAPSULE ENDOSCOPY; DRUG MONITORING; DRUG SOLUBILITY; INGESTION; MEDICATION COMPLIANCE; RADIOFREQUENCY IDENTIFICATION; SIDE EFFECT; GENETIC PROCEDURES; HUMAN; RADIO FREQUENCY IDENTIFICATION DEVICE;

BIOSENSING TECHNIQUES; GELATIN; HUMANS; MEDICATION ADHERENCE; RADIO FREQUENCY IDENTIFICATION DEVICE;

EID: 84948386702     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-015-0494-8     Document Type: Article

References (40)

1. Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol. 1997;50(4):385–91.
2. Institute NEH. Thinking outside the pillbox: a system‐wide approach to improving patient medication adherence for chronic disease. New England Healthcare Institute Research Brief: New England Healthcare Institute 2009.
3. Miller LG, Liu H, Hays RD, Golin CE, Beck CK, Asch SM, et al. How well do clinicians estimate patients’ adherence to combination antiretroviral therapy? J Gen Intern Med. 2002;17(1):1–11.
4. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97. doi:10.1056/NEJMra050100.
5. Rudd P, Byyny RL, Zachary V, LoVerde ME, Mitchell WD, Titus C, et al. Pill count measures of compliance in a drug trial: variability and suitability. Am J Hypertens. 1988;1(3 Pt 1):309–12.
6. DiCarlo L, Moon G, Intondi A, Duck R, Frank J, Hafazi H, et al. A digital health solution for using and managing medications: wirelessly observed therapy. IEEE Pulse. 2012;3(5):23–6. doi:10.1109/mpul.2012.2205777.
7. BIO E. Etect. http://etectbio.com. January 2015.
8. Kane JM, Perlis RH, DiCarlo LA, Au‐Yeung K, Duong J, Petrides G. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder. J Clin Psychiatry. 2013;74(6):e533–40. doi:10.4088/JCP.12m08222.
9. Boyer EW, Smelson D, Fletcher R, Ziedonis D, Picard RW. Wireless technologies, ubiquitous computing and mobile health: application to drug abuse treatment and compliance with HIV therapies. J Med Toxicol Off J Am Coll Med Toxicol. 2010;6(2):212–6. doi:10.1007/s13181-010-0080-z.
10. Horvath KJ, Carrico AW, Simoni J, Boyer EW, Amico KR, Petroll AE. Engagement in HIV medical care and technology use among stimulant‐using and nonstimulant‐using men who have sex with men. AIDS Res Treat. 2013;2013:121352. doi:10.1155/2013/121352.
11. Moore JO, Boyer EW, Safren S, Robbins GK, Boudreaux ED, Rosen R, et al. Designing interventions to overcome poor numeracy and improve medication adherence in chronic illness, including HIV/AIDS. J Med Toxicol Off J Am Coll Med Toxicol. 2011;7(2):133–8. doi:10.1007/s13181-011-0149-3.
12. Rosen RK, Ranney M, Boyer EW. Formative research for mHealth HIV adherence: the iHAART app. Annual Hawaii International Conference on System Sciences. Hawaii: IEEE & Computer Society Press; 2015. p. 2779–85.
13. Yuce MR, Dissanayake T. Easy-to-swallow wireless telemetry. Microwave Mag IEEE. 2012;13(6):90–101.
14. Frehill P, Chambers D, Rotariu C. Using Zigbee to integrate medical devices. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Conference. 2007; 2007: 6718–21. doi: 10.1109/iembs.2007.4353902.
15. Gomez C, Oller J, Paradells J. Overview and evaluation of bluetooth low energy: an emerging low-power wireless technology. Sensors. 2012;12:11734–53.
16. Li F, Leighton JA, Sharma VK. Capsule endoscopy: a comprehensive review. Minerva Gastroenterol Dietol. 2007;53(3):257–72.
17. Ou JZ, Yao CK, Rotbart A, Muir JG, Gibson PR, Kalantar-Zadeh K. Human intestinal gas measurement systems: in vitro fermentation and gas capsules. Trends Biotechnol. 2015. doi:10.1016/j.tibtech.2015.02.002.
18. Adib F, Mao H, Kabelac Z, Katabi D, Miller RC. Smart homes that monitor breathing and heart rate. Seoul: CHI 2015 Crossings; 2015.
19. Belknap R, Weis S, Brookens A, Au-Yeung KY, Moon G, DiCarlo L, et al. Feasibility of an ingestible sensor‐based system for monitoring adherence to tuberculosis therapy. PLoS One. 2013;8(1):e53373. doi:10.1371/journal.pone.0053373.
20. Kumar P, Lee HJ. Security issues in healthcare applications using wireless medical sensor networks: a survey. Sensors (Basel, Switzerland). 2012;12(1):55–91. doi:10.3390/s120100055.
21. He D, Chan S, Tang S. A novel and lightweight system to secure wireless medical sensor networks. IEEE J Biomed Health Inform. 2014;18(1):316–26. doi:10.1109/jbhi.2013.2268897.
22. He D, Chen C, Chan S, Bu J, Zhang P. Secure and lightweight network admission and transmission protocol for body sensor networks. IEEE J Biomed Health Informatics. 2013;17(3):664–74.
23. Kovac C. “Video pill” may supplement standard endoscopy. BMJ (Clin Res ed). 2001;323(7309):358.
24. Li F, Gurudu SR, De Petris G, Sharma VK, Shiff AD, Heigh RI, et al. Retention of the capsule endoscope: a single-center experience of 1000 capsule endoscopy procedures. Gastrointest Endosc. 2008;68(1):174–80. doi:10.1016/j.gie.2008.02.037.
25. Helander HF, Fandriks L. Surface area of the digestive tract—revisited. Scand J Gastroenterol. 2014;49(6):681–9. doi:10.3109/00365521.2014.898326.
26. Acierno R, Carata E, DePascali S, Fanizzi F, Maffia M, Mainetti L, et al. Potential effects of RFID systems on biotechnology insulin preparation: a study using HPLC and NMR spectroscopy. IEEE/ICME Conference on Complex Medical Engineering; Gold Coast, Australia: IEEE; 2010. p. 198–203.
27. Perry CM, Noble S. Saquinavir soft‐gel capsule formulation. A review of its use in patients with HIV infection. Drugs. 1998;55(3):461–86.
28. Vita R, Fallahi P, Antonelli A, Benvenga S. The administration of L‐thyroxine as soft gel capsule or liquid solution. Expert Opin Drug Deliv. 2014;11(7):1103–11. doi:10.1517/17425247.2014.918101.
29. Klein CE, Chiu YL, Awni W, Zhu T, Heuser RS, Doan T, et al. The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect. J Acquir Imm Def Syndr (1999). 2007;44(4):401–10. doi:10.1097/QAI.0b013e31803133c5.
30. Acierno R, DePascali S, Fanizzi F, Maffia M, Mainetti L, Patrono L, et al. Investigating potential effects of RFID systems on the molecular structure of the human insulin. 5th Cairo International Biomedical Engineering Conference; 2010; Cairo: IEEE; 2010.
31. Kozakova S, Gonec R. RFID technology in preparation and administration of cytostatic infusions, deploying RFID—challenges, solutions, and open issues. InTech. 2011. http://www.intechopen.com/books/deploying‐rfid‐challenges‐solutions‐and‐open‐issues/rfid-technology-in‐preparation‐and‐administration‐of‐cytostatic‐infusions. Accessed May 11, 2015.
32. Birnbaum F, Lewis D, Rosen RK, Ranney ML. Patient engagement and the design of digital health. Acad Emerg Med Off J Soc Acad Emerg Med. 2015;22(6):754–6. doi:10.1111/acem.12692.
33. Royce W, editor. Managing the development of large software systems. IEEE WESCON; 1970: Proceedings of IEEE WESCON.
34. Whitworth E, Biddle R. The social nature of agile teams. Agile Conference IEEE; 2007. p. 26–36.
35. Ranney ML, Choo EK, Wang Y, Baum A, Clark MA, Mello MJ. Emergency department patients’ preferences for technology‐based behavioral interventions. Ann Emerg Med. 2012;60(2):218–27.e48. doi:10.1016/j.annemergmed.2012.02.026.
36. Carroll A, G H. An analysis of power consumption in a smartphone. USENIX Annual Technical Conference; 2010; Boston: Proceedings of the 2010 USENIX Annual Technical Conference; 2010.
37. Grossberg R, Zhang Y, Gross R. A time‐to‐prescription‐refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57(10):1107–10. doi:10.1016/j.jclinepi.2004.04.002.
38. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. The Cochrane database of systematic reviews. 2002;(2):Cd000011. doi:10.1002/14651858.cd000011.
39. Castillo‐Mancilla JR, Searls K, Caraway P, Zheng JH, Gardner EM, Predhomme J, et al. Short communication: tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV‐infected women. AIDS Res Hum Retrovir. 2015;31(4):428–32. doi:10.1089/aid.2014.0229.
40. Organization WH. Adherence to long‐term therapies: evidence for action. Geneva: World Health Organization; 2003.